NDC properties for "Revlimid 5 MG Oral Capsule" (RxCUI 616116)
About this data
The tables show NDC propoerties for Revlimid 5 MG Oral Capsule with the RxCUI 616116
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Revlimid 5 MG Oral Capsule (RxCUI 616116)
| MMSL_CODE | BD15733 |
|---|---|
| NDA | NDA021880 |
| RxCUI | 616116 |
| SPL_SET_ID | 5fa97bf5-28a2-48f1-8955-f56012d296be |
| Prescribable Synonym | Revlimid 5 MG Oral Capsule |
| RXNAV_STR | Revlimid 5 MG Oral Capsule |
| RxNorm Name | lenalidomide 5 MG Oral Capsule [Revlimid] |
| RxNorm Synonym | Revlimid 5 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 616116) |
NDC Properties
NDC Item 59572040500
| NDC 9 | 59572-405 |
|---|---|
| NDC 10 | 59572-405-00 |
| NDC Item | 59572040500 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-405-00) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-12-27 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-405 |
NDC Item 59572040528
| NDC 9 | 59572-405 |
|---|---|
| NDC 10 | 59572-405-28 |
| NDC Item | 59572040528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59572-405-28) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-12-27 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-405 |
NDC Item 59572040500
| NDC 9 | 59572-405 |
|---|---|
| NDC 10 | 59572-405-00 |
| NDC Item | 59572040500 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-405-00) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-12-27 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-405 |
NDC Item 59572040528
| NDC 9 | 59572-405 |
|---|---|
| NDC 10 | 59572-405-28 |
| NDC Item | 59572040528 |
| Packaging | 28 CAPSULE in 1 BOTTLE (59572-405-28) |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 584719 |
| Imprint code | REV;5;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2005-12-27 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 59572-405 |